Monoclonal antibody therapy for prostate cancer: finally a reality?
- PMID: 15173211
- DOI: 10.1200/JCO.2004.04.901
Monoclonal antibody therapy for prostate cancer: finally a reality?
Comment on
-
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer.J Clin Oncol. 2004 Jul 1;22(13):2522-31. doi: 10.1200/JCO.2004.09.154. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173215 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous